Skin Testing to Identify Safe Drugs for Patients with Rocuronium-Induced Anaphylaxis
Among patients who develop anaphylaxis during anesthesia, anaphylaxis caused by a neuromuscular blocking agent has the highest incidence. In patients who developed IgE-mediated anaphylaxis, and cross-reactivity among NMBAs is a concern in subsequent anesthetic procedures. We present a patient who de...
Saved in:
Main Authors: | Manzo Suzuki, Hajime Kawase, Azusa Ogita, Hiroyasu Bito |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Anesthesiology |
Online Access: | http://dx.doi.org/10.1155/2020/8163620 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Negative Pressure Pulmonary Edema after Reversing Rocuronium-Induced Neuromuscular Blockade by Sugammadex
by: Manzo Suzuki, et al.
Published: (2014-01-01) -
Sensitivity to Rocuronium-Induced Neuromuscular Block and Reversibility with Sugammadex in a Patient with Myotonic Dystrophy
by: Akihiro Kashiwai, et al.
Published: (2012-01-01) -
The Effect of Patient Weight and Provider Training and Experience on Dosing of Rocuronium
by: N. C. Godwin, et al.
Published: (2016-01-01) -
Encapsulation of Vecuronium and Rocuronium by Sugammadex Investigated by Surface-Enhanced Raman Spectroscopy
by: Adriana Kenđel, et al.
Published: (2025-01-01) -
Assessment of medical students’ knowledge of anaphylaxis
management
by: Anna Rapiejko, et al.
Published: (2024-02-01)